Cuprina Holdings (Cayman) (CUPR) Liabilities and Shareholders Equity (2023 - 2025)
Cuprina Holdings (Cayman) (CUPR) reported Liabilities and Shareholders Equity of $10.8 million for Q2 2025, up 724.88% quarter-over-quarter from $1.3 million in Q4 2024.
Cuprina Holdings (Cayman) (CUPR) Liabilities and Shareholders Equity (2023 - 2025) Analysis & Trends
Cuprina Holdings (Cayman) has reported Liabilities and Shareholders Equity for 3 years, with the latest figure at $10.8 million in Q2 2025.
- For the quarter ending Q2 2025, Liabilities and Shareholders Equity changed N/A year-over-year to $10.8 million; the trailing twelve-month figure through Dec 2025 stood at $13.3 million (changed N/A YoY), and the FY2024 full-year result was $1.3 million, up 11.22% from the prior year.
- Liabilities and Shareholders Equity for Q2 2025 stood at $10.8 million, up from $1.3 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $10.8 million in Q2 2025, with the low at $1.2 million in Q4 2023.
- Historically, Liabilities and Shareholders Equity has averaged $4.4 million across 3 years, with a median of $1.3 million in 2024.
- The largest YoY upside for Liabilities and Shareholders Equity was 11.69% in 2024 against a maximum downside of 11.69% in 2024.
- Cuprina Holdings (Cayman)'s Liabilities and Shareholders Equity stood at $1.2 million in 2023, then gained by 11.69% to $1.3 million in 2024, then jumped by 724.88% to $10.8 million in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $10.8 million (Q2 2025), $1.3 million (Q4 2024), and $1.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Cuprina Holdings (Cayman) | 83.08 Mn | 83.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 10.82 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.17 Mn |